About Renepharmaceuticals
Renepharmaceuticals is a company based in India. The company has 27 employees as of April 07, 2024. Renepharmaceuticals offers products and services including KETORITE and RENECAR.
- Headquarter India
- Employees 27 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Rene Pharmaceuticals Private Limited
- Date of Incorporation 17 Mar, 2016
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$1.6 M (USD)-23.29as on Mar 31, 2022
-
Net Profit
$62.02 K (USD)-19.2as on Mar 31, 2022
-
EBITDA
$78.23 K (USD)-27.02as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
27
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renepharmaceuticals
Renepharmaceuticals offers a comprehensive portfolio of products and services, including KETORITE and RENECAR.
Alpha Ketoanalogue Tablets are provided for the management of renal conditions.
Sevelamer Carbonate Tablets are offered for controlling phosphate levels in kidney patients.
Funding Insights of Renepharmaceuticals
Detailed funding history for Renepharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Renepharmaceuticals
Investment portfolio details for Renepharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Renepharmaceuticals
Detailed financials for Renepharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renepharmaceuticals Comparisons
Peer comparison for Renepharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Renepharmaceuticals
Detailed competitors of Renepharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renepharmaceuticals
Complete news archive for Renepharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renepharmaceuticals
Renepharmaceuticals is headquartered in India.
As of Apr 07, 2024, the latest employee count at Renepharmaceuticals is 27.
Annual revenue of Renepharmaceuticals is $1.6M as on Mar 31, 2022.
Rene Pharmaceutical Pvt. Ltd. was established in 2013 and has been recognized as a trusted entity in the market for healthcare products, including dialysis and transplant medications. A wide range of products is traded to enhance quality of life, with rigorous quality checks conducted to ensure conformity with industry norms. The company is focused on providing medicines for renal diseases at affordable prices, while efforts are made to improve the well-being of kidney patients through reliable offerings. Overall, high compatibility and cost-effectiveness are maintained in the products supplied.
Renepharmaceuticals offers KETORITE and RENECAR.